Hedge Fund - Prescott Group Capital Management

Managed by Phil Frohlich, Prescott Group Capital Management has recently revealed its equity portfolio allocation for the first quarter of 2014, according to the fund's latest 13F filing with the Securities...

Phil Frohlich’s Prescott Group Capital Management has disclosed owning an aggregate 3.94 million shares of 4Licensing Corp (OTCMKTS:FOUR).

In the current round of 13F filings, hedge funds and other institutional investors are disclosing their equity portfolios as held at the end of the last year.

Phil Frohlich's Prescott Group Capital Management, in a filing with Securities and Exchange Commission, revealed that it owns 2.03 million shares of Comstock Holding Companies Inc (NASDAQ:CHCI), which...

Phil Frohlich's Prescott Group Capital Management has disclosed, in a new filing with the Securities and Exchange Commission, owning around 1.9 million shares of Comstock Holding Companies Inc (NASDAQ...

Update: According to a statement on Theraclone's website, the merger agreement between Theraclone Sciences and PharmAthene, Inc. (NYSEMKT:PIP) has been terminated.

Phil Frohlich's Prescott Group Capital Management, insists that shareholders of PharmAthene, Inc. (NYSEMKT:PIP) should vote against the merger with Thercalone Sciences.

Phil Frohlich's fund Prescott Group Capital Management disclosed, in a newly amended filing with the Securities and Exchange Commission, that it has recently upgraded its holding in Bluephoenix Solutions...

Phil Frohlich's Prescott Group Capital Management, has provided, in a newly amended filing with the Securities and Exchange Commission, an update on its negotiations with the board of PharmAthene, Inc...